wineberry
22 May 2017
Fund Managers Board gone very quiet for the last year! Worth reading the news item of 18/05/17 - 'Fund Manager's favourite small cap pharma shares' This is a new company to me but looks pretty interesting with its sharp increase in revenues and moving into profit. It has a PEG ratio well under 1, which was always one of the indicators sought by Jim Slater.
